US Lawyer Database

Section 21-28-4.07. – Distribution to persons under age 18.

§ 21-28-4.07. Distribution to persons under age 18. (a) Any person eighteen (18) years of age or over who violates § 21-28-4.01(a) by distributing a controlled substance, excluding marijuana, listed in schedules I and II to a person under eighteen (18) years of age who is at least three (3) years his or her junior […]

Section 21-28-4.07.1. – Distribution or manufacturing in or near schools.

§ 21-28-4.07.1. Distribution or manufacturing in or near schools. Any person who violates § 21-28-4.01(A), 21-28-4.01.1, or 21-28-4.07 by distributing or manufacturing a controlled substance listed in schedules I or II in the building or on the grounds, or within three hundred (300) yards of the grounds of a public or private elementary, vocational, or […]

Section 21-28-4.08. – Conspiracy.

§ 21-28-4.08. Conspiracy. Any person who conspires to violate any provision of this chapter is guilty of a crime and is subject to the same punishment prescribed in this chapter for the commission of the substantive offense of which there is a conspiracy to violate. History of Section.P.L. 1974, ch. 183, § 2.

Section 21-28-4.09. – General penalty clause.

§ 21-28-4.09. General penalty clause. Any person who violates any provision of this chapter, the penalty for which is not specified in this chapter, and of the rules and regulations of the director of health made under authority of this chapter, shall be sentenced to a term of imprisonment of not more than one year, […]

Section 21-28-3.31. – Use of imitation controlled substance in research — Immunity.

§ 21-28-3.31. Use of imitation controlled substance in research — Immunity. No civil or criminal liability shall be imposed by virtue of this chapter on any practitioner, apothecary, or other person registered under this chapter who manufactures, distributes, or possesses an imitation controlled substance for use as a placebo by a registered practitioner in the […]

Section 21-28-3.32. – Electronic prescription database. [Effective until January 1, 2023.]

§ 21-28-3.32. Electronic prescription database. [Effective until January 1, 2023.] (a) The information contained in any prescription-drug-monitoring database maintained by the department of health pursuant to § 21-28-3.18 shall be disclosed only: (1) To a practitioner who certifies that the requested information is for the purpose of evaluating the need for, or providing medical treatment […]